Page:Senator Marco Rubio's Letter to Pfizer, RE COVID Mutation Research.pdf/2

This page has been proofread, but needs to be validated.
2. Does Pfizer intend to continue mutating the SARS-CoV-2 virus through gain-of-function, or directed evolution research, with the purpose of creating new vaccines before the variant is present in the greater population?
3. Has Pfizer engaged with federal officials engaged regarding their plans to oversee this research? Please provide the names and agencies for these individuals.
4. What steps has Pfizer taken to ensure the mutated virus does not leak from the laboratory and infect the greater population?
5. Has Pfizer engaged with other biopharmaceutical companies to collaborate on this research effort? Please list the entities that you have been in contact with.
6. Will you commit to halting any future research that mutates the SARS-CoV-2 vaccine as substantial evidence has indicated that similar dangerous research at the Wuhan Institute of Virology very likely led to the initial emergence and global spread of the virus?

As a leader in global public health and development of the COVID vaccine, with American taxpayer dollars, it is critical that Pfizer is accountable for their actions and be transparent with the public on the substance and intent of their research.

Thank you for your attention to this matter. I look forward to your prompt response.


Sincerely,
M< R
Marco Rubio
U.S. Senator